These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29802836)

  • 1. False-positive amphetamine results on several drug screening platforms due to mexiletine.
    Snozek CLH; Kaleta EJ; Jannetto PJ; Linkenmeyer JJ; Harnish TL; Stephen J; Langman LJ
    Clin Biochem; 2018 Aug; 58():125-127. PubMed ID: 29802836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced interference by phenothiazines in amphetamine drug of abuse immunoassays.
    Melanson SE; Lee-Lewandrowski E; Griggs DA; Long WH; Flood JG
    Arch Pathol Lab Med; 2006 Dec; 130(12):1834-8. PubMed ID: 17149959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of false positive amphetamine screens due to bupropion using the Syva EMIT II immunoassay.
    Casey ER; Scott MG; Tang S; Mullins ME
    J Med Toxicol; 2011 Jun; 7(2):105-8. PubMed ID: 21191682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ranitidine interference with standard amphetamine immunoassay.
    Liu L; Wheeler SE; Rymer JA; Lower D; Zona J; Peck Palmer OM; Tamama K
    Clin Chim Acta; 2015 Jan; 438():307-8. PubMed ID: 25242739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detectability of new psychoactive substances, 'legal highs', in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuse.
    Beck O; Rausberg L; Al-Saffar Y; Villen T; Karlsson L; Hansson T; Helander A
    Drug Test Anal; 2014 May; 6(5):492-9. PubMed ID: 24665024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of six commercial amphetamine and methamphetamine immunoassays for cross-reactivity to phenylpropanolamine and ephedrine in urine.
    D'Nicuola J; Jones R; Levine B; Smith ML
    J Anal Toxicol; 1992; 16(4):211-3. PubMed ID: 1501473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetracaine from urethral ointment causes false positive amphetamine results by immunoassay.
    Wijngaard R; Parra-Robert M; Marés L; Escalante A; Salgado E; González-de-la-Presa B; To-Figueras J; Brunet M
    Clin Toxicol (Phila); 2021 Jun; 59(6):500-505. PubMed ID: 33112680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
    Lu NT; Taylor BG
    Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. False-Positive Amphetamines in Urine Drug Screens: A 6-Year Review.
    Pope JD; Drummer OH; Schneider HG
    J Anal Toxicol; 2023 Mar; 47(3):263-270. PubMed ID: 36367744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-Reactivity of Chloroquine and Hydroxychloroquine With DRI Amphetamine Immunoassay.
    Gomila I; Quesada L; López-Corominas V; Fernández J; Servera MÁ; Sahuquillo L; Dastis M; Torrents A; Barceló B
    Ther Drug Monit; 2017 Apr; 39(2):192-196. PubMed ID: 28207572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of Detection of New Amphetamine-Like Drugs Using Conventional Urinary Immunoassays.
    Begeman A; Franssen EJF
    Ther Drug Monit; 2018 Feb; 40(1):135-139. PubMed ID: 29194289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactivity studies and predictive modeling of "Bath Salts" and other amphetamine-type stimulants with amphetamine screening immunoassays.
    Petrie M; Lynch KL; Ekins S; Chang JS; Goetz RJ; Wu AH; Krasowski MD
    Clin Toxicol (Phila); 2013 Feb; 51(2):83-91. PubMed ID: 23387345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of the Emit II amphetamine/methamphetamine assay to specimens collected following use of Vicks inhalers.
    Poklis A; Jortani SA; Brown CS; Crooks CR
    J Anal Toxicol; 1993 Sep; 17(5):284-6. PubMed ID: 8107462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buflomedil interference with the monoclonal EMIT d.a.u. amphetamine/methamphetamine immunoassay.
    Papa P; Rocchi L; Mainardi C; Donzelli G
    Eur J Clin Chem Clin Biochem; 1997 May; 35(5):369-70. PubMed ID: 9189741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The trazodone metabolite meta-chlorophenylpiperazine can cause false-positive urine amphetamine immunoassay results.
    Baron JM; Griggs DA; Nixon AL; Long WH; Flood JG
    J Anal Toxicol; 2011 Jul; 35(6):364-8. PubMed ID: 21740694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays.
    Pettersson Bergstrand M; Helander A; Hansson T; Beck O
    Drug Test Anal; 2017 Apr; 9(4):640-645. PubMed ID: 27366870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovering Cross-Reactivity in Urine Drug Screening Immunoassays through Large-Scale Analysis of Electronic Health Records.
    Hughey JJ; Colby JM
    Clin Chem; 2019 Dec; 65(12):1522-1531. PubMed ID: 31578215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMIT-d.a.u. monoclonal amphetamine/methamphetamine assay. I. Stereoselectivity and clinical evaluation.
    Poklis A; Hall KV; Eddleton RA; Fitzgerald RL; Saady JJ; Bogema SC
    Forensic Sci Int; 1993 Apr; 59(1):49-62. PubMed ID: 8505029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive predictive values of abused drug immunoassays on the Beckman Synchron in a veteran population.
    Dietzen DJ; Ecos K; Friedman D; Beason S
    J Anal Toxicol; 2001 Apr; 25(3):174-8. PubMed ID: 11327349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability amongst urine toxicology amphetamine readings with concurrent administration of fenofibrate.
    Dadlani N; Farrar A; Jones G
    Australas Psychiatry; 2018 Feb; 26(1):24-26. PubMed ID: 28699773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.